Abbott Financial Statements From 2010 to 2022

ABT -  USA Stock  

USD 109.45  3.24  3.05%

Abbott Laboratories financial statements provide useful quarterly and yearly information to potential Abbott Laboratories investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Abbott Laboratories financial statements helps investors assess Abbott Laboratories' valuation, profitability, and current liquidity needs.
There are currently one hundred sixteen fundamental signals for Abbott Laboratories that can be evaluated and compared over time across rivals. Make sure you validate Abbott Laboratories' prevailing fundamentals against the performance from 2010 to 2022 and make sure the trends continue to evolve in the right direction.
Abbott Laboratories Revenue Per Employee is comparatively stable at the moment as compared to the past year. Abbott Laboratories reported Revenue Per Employee of 381,195 in 2021. Invested Capital is likely to gain to about 35.1 B in 2022, whereas Earnings Before Interest Taxes and Depreciation Amortization EBITDA are likely to drop slightly above 10.6 B in 2022.
  
Refresh
Check Abbott Laboratories financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Abbott main balance sheet or income statement drivers, such as Direct Expenses of 15.2 B, Consolidated Income of 5.8 B or Cost of Revenue of 16.4 B, as well as many exotic indicators such as Interest Coverage of 19.14, Long Term Debt to Equity of 0.48 or Calculated Tax Rate of 16.05. Abbott financial statements analysis is a perfect complement when working with Abbott Laboratories Valuation or Volatility modules. It can also supplement various Abbott Laboratories Technical models. Please continue to the analysis of Abbott Laboratories Correlation against competitors.

Abbott Laboratories Revenues

37.89 Billion

Share

Abbott Laboratories Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets74.6 B75.2 B61.5 B
Increasing
Slightly volatile
Cash and Equivalents8.8 B9.8 B8.6 B
Decreasing
Stable
Investments1.3 B1.3 B1.1 B
Increasing
Stable
Investments Current402.6 M405 M442.9 M
Decreasing
Slightly volatile
Investments Non Current1.1 B816 M1.1 B
Increasing
Stable
Property Plant and Equipment Net8.9 BB7.5 B
Increasing
Slightly volatile
Inventory4.8 B5.2 B3.6 B
Increasing
Slightly volatile
Tax Assets4.3 B5.2 B3.8 B
Decreasing
Slightly volatile
Trade and Non Trade Receivables5.6 B6.5 B5.5 B
Decreasing
Stable
Trade and Non Trade Payables3.6 B4.4 B2.3 B
Increasing
Slightly volatile
Goodwill and Intangible Assets35.3 B36 B28.7 B
Increasing
Slightly volatile
Total Liabilities39.7 B39.2 B33.7 B
Increasing
Slightly volatile
Shareholders Equity34.9 B36 B27.8 B
Increasing
Slightly volatile
Accumulated Retained Earnings Deficit31.1 B31.5 B25.1 B
Increasing
Slightly volatile
Current Assets21.3 B24.2 B20.7 B
Decreasing
Stable
Assets Non Current50 B51 B40.6 B
Increasing
Slightly volatile
Current Liabilities11.4 B13.1 B11.2 B
Decreasing
Slightly volatile
Liabilities Non Current26.6 B26.1 B22.4 B
Increasing
Slightly volatile
Tax Liabilities304.2 M306 M350.8 M
Decreasing
Slightly volatile
Total Debt19.2 B18.1 B16.8 B
Increasing
Slightly volatile
Debt Current773.8 M754 MB
Decreasing
Slightly volatile
Debt Non Current17.7 B17.3 B14.8 B
Increasing
Slightly volatile
Shareholders Equity USD34.9 B36 B27.8 B
Increasing
Slightly volatile
Cash and Equivalents USD8.8 B9.8 B8.6 B
Decreasing
Stable
Total Debt USD19.2 B18.1 B16.8 B
Increasing
Slightly volatile
Accounts Payable4.8 B4.4 B2.4 B
Increasing
Slightly volatile
Receivables6.6 B6.5 B5.5 B
Decreasing
Very volatile
Inventories4.2 B5.2 B3.6 B
Increasing
Slightly volatile

Abbott Laboratories Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Revenues37.9 B43.1 B26.8 B
Increasing
Slightly volatile
Cost of Revenue16.4 B18.5 B11.8 B
Increasing
Slightly volatile
Selling General and Administrative Expense10.7 B11.3 B8.3 B
Increasing
Slightly volatile
Research and Development Expense2.5 B2.7 B1.9 B
Increasing
Slightly volatile
Operating Expenses15.1 B16.1 B11.5 B
Increasing
Slightly volatile
Interest Expense546.2 M533 M457.9 M
Increasing
Slightly volatile
Income Tax Expense909.2 M1.1 B530.2 M
Increasing
Slightly volatile
Consolidated Income5.8 B7.1 B3.8 B
Increasing
Stable
Net Income5.8 B7.1 B3.8 B
Increasing
Stable
Net Income Common Stock5.8 B7.1 B3.8 B
Increasing
Stable
Weighted Average Shares1.9 B1.8 B1.6 B
Increasing
Slightly volatile
Weighted Average Shares Diluted1.9 B1.8 B1.7 B
Increasing
Slightly volatile
Earning Before Interest and Taxes EBIT7.3 B8.7 B4.8 B
Increasing
Slightly volatile
Revenues USD37.9 B43.1 B26.8 B
Increasing
Slightly volatile
Net Income Common Stock USD5.8 B7.1 B3.8 B
Increasing
Stable
Earning Before Interest and Taxes USD7.3 B8.7 B4.8 B
Increasing
Slightly volatile
Gross Profit21.4 B24.5 B15 B
Increasing
Slightly volatile
Operating Income9.1 B8.4 B3.7 B
Increasing
Slightly volatile
Direct Expenses15.2 B18.5 B13 B
Increasing
Stable

Abbott Laboratories Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Net Cash Flow Business Acquisitions and Disposals(57.2 M)(53 M)(890.2 M)
Increasing
Very volatile
Net Cash Flow Investment Acquisitions and Disposals(103.6 M)(96 M)(40 M)
Increasing
Very volatile
Net Cash Flow from Financing(5.6 B)(5.5 B)(3.6 B)
Decreasing
Very volatile
Issuance Repayment of Debt Securities (254.5 M)(248 M)(17.3 M)
Decreasing
Very volatile
Issuance Purchase of Equity Shares(2.1 B)(2 B)(642.8 M)
Decreasing
Slightly volatile
Net Cash Flow from Investing(2.2 B)(2 B)(2.1 B)
Decreasing
Stable
Net Cash Flow from Operations9.1 B10.5 B6.6 B
Increasing
Stable
Effect of Exchange Rate Changes on Cash (75.5 M)(70 M)(75.9 M)
Increasing
Very volatile
Net Cash Flow or Change in Cash and Cash Equivalents3.2 BB962.4 M
Decreasing
Very volatile
Share Based Compensation574.4 M640 M420.9 M
Increasing
Slightly volatile
Depreciation Amortization and Accretion3.3 B3.5 B2.7 B
Increasing
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Earnings per Basic Share4.283.972.4072
Increasing
Very volatile
Earnings per Diluted Share4.253.942.3894
Increasing
Very volatile
Earnings per Basic Share USD4.283.972.4072
Increasing
Very volatile
Dividends per Basic Common Share1.691.81.3538
Decreasing
Very volatile
Return on Average Equity0.160.2040.1382
Decreasing
Stable
Return on Average Assets0.07650.0960.0642
Decreasing
Stable
Return on Invested Capital0.210.2610.1722
Decreasing
Very volatile
Gross Margin0.630.570.5606
Increasing
Slightly volatile
Profit Margin0.140.1640.1486
Decreasing
Slightly volatile
EBITDA Margin0.270.2850.2838
Decreasing
Slightly volatile
Return on Sales0.180.2030.1834
Decreasing
Slightly volatile
Asset Turnover0.570.5840.4498
Increasing
Slightly volatile
Payout Ratio0.460.4530.8465
Increasing
Very volatile
Enterprise Value over EBITDA20.8121.00316.7619
Increasing
Slightly volatile
Enterprise Value over EBIT35.7930.027.2915
Increasing
Slightly volatile
Price to Earnings Ratio46.6435.45145.9161
Increasing
Stable
Sales per Share21.9624.26816.1733
Increasing
Slightly volatile
Price to Sales Ratio5.475.84.269
Increasing
Slightly volatile
Price to Book Value5.946.9084.1014
Increasing
Slightly volatile
Debt to Equity Ratio1.071.0871.2052
Decreasing
Stable
Dividend Yield0.01470.01170.0206
Decreasing
Slightly volatile
Current Ratio1.811.851.9238
Increasing
Very volatile
Free Cash Flow per Share4.224.8723.1034
Decreasing
Very volatile
Book Value per Share20.3420.29516.8924
Increasing
Slightly volatile
Tangible Assets Book Value per Share19.9422.09919.9437
Decreasing
Stable
Total Assets Per Share37.9642.626136.9541
Increasing
Stable
Cash Flow Per Share5.45.97084.0101
Increasing
Very volatile
Return on Investment14.5515.989310.9083
Decreasing
Stable
Operating Margin18.6919.558914.8277
Increasing
Very volatile
Calculated Tax Rate16.0513.883820.4094
Increasing
Very volatile
Receivables Turnover5.886.67785.6498
Increasing
Slightly volatile
Inventory Turnover4.083.64583.7553
Decreasing
Slightly volatile
PPandE Turnover4.894.78934.158
Increasing
Very volatile
Cash and Equivalents Turnover4.795.17824.8889
Increasing
Very volatile
Accounts Payable Turnover15.110.312416.5888
Decreasing
Slightly volatile
Accrued Expenses Turnover5.115.73724.993
Increasing
Slightly volatile
Interest Coverage19.1417.193917.5621
Decreasing
Stable
Long Term Debt to Equity0.480.48310.5292
Increasing
Stable
Quick Ratio1.231.27711.3214
Increasing
Very volatile
Net Current Assets as percentage of Total Assets16.9714.806615.9371
Decreasing
Stable
Revenue to Assets0.590.57280.5111
Decreasing
Stable

Abbott Laboratories Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Earnings before Tax6.7 B8.2 B4.4 B
Increasing
Slightly volatile
Earnings Before Interest Taxes and Depreciation Amortization EBITDA10.6 B12.3 B7.5 B
Increasing
Slightly volatile
Earnings Before Interest Taxes and Depreciation Amortization USD10.6 B12.3 B7.5 B
Increasing
Slightly volatile
Market Capitalization197.5 B248.9 B119.2 B
Increasing
Slightly volatile
Enterprise Value207.3 B258 B128 B
Increasing
Slightly volatile
Invested Capital35.1 B34.4 B29.6 B
Increasing
Slightly volatile
Average Equity34 B34.6 B27.7 B
Increasing
Slightly volatile
Average Assets72.9 B73.8 B60.2 B
Increasing
Slightly volatile
Invested Capital Average33.9 B33.6 B28.5 B
Increasing
Slightly volatile
Tangible Asset Value34.2 B39.2 B32.4 B
Decreasing
Very volatile
Free Cash Flow7.3 B8.6 B5.1 B
Increasing
Very volatile
Working Capital9.9 B11.1 B9.5 B
Decreasing
Very volatile
Revenue Per Employee391.5 K381.2 K334.5 K
Decreasing
Stable
Net Income Per Employee56.1 K62.6 K41.2 K
Decreasing
Very volatile

Abbott Fundamental Market Drivers

Forward Price Earnings21.43
Short Percent Of Float0.79%
Average Daily Volume Last 10 Day5.19M
Shares Short Prior Month12.1M
Average Daily Volume In Three Month5.32M
Date Short Interest29th of April 2022
Fifty Day Average113.72
Two Hundred Day Average122.72

Abbott Upcoming Events

Upcoming Quarterly Report26th of January 2022
Next Financial Report19th of April 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End26th of January 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

About Abbott Laboratories Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Abbott Laboratories income statement, its balance sheet, and the statement of cash flows. Abbott Laboratories investors use historical funamental indicators, such as Abbott Laboratories's revenue or net income, to determine how well the company is positioned to perform in the future. Although Abbott Laboratories investors may use each financial statement separately, they are all related. The changes in Abbott Laboratories's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Abbott Laboratories's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Abbott Laboratories Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Abbott Laboratories. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Cost of Revenue18.5 B16.4 B
Revenues43.1 B37.9 B
Revenue to Assets 0.57  0.59 
Revenue Per Employee381.2 K391.5 K
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois. Abbott Laboratories operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 113000 people.

Abbott Laboratories Investors Sentiment

The influence of Abbott Laboratories' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Abbott. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Abbott Laboratories Implied Volatility

    
  32.64  
Abbott Laboratories' implied volatility exposes the market's sentiment of Abbott Laboratories stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Abbott Laboratories' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Abbott Laboratories stock will not fluctuate a lot when Abbott Laboratories' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Abbott Laboratories in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Abbott Laboratories' short interest history, or implied volatility extrapolated from Abbott Laboratories options trading.

Current Sentiment - ABT

Abbott Laboratories Investor Sentiment

Predominant part of Macroaxis users are presently bullish on Abbott Laboratories. What is your sentiment towards investing in Abbott Laboratories? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish

Pair Trading with Abbott Laboratories

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Abbott Laboratories position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abbott Laboratories will appreciate offsetting losses from the drop in the long position's value.

Abbott Laboratories Pair Correlation

Correlation Analysis For Direct Indexing and Tax-loss Harvesting

The ability to find closely correlated positions to Abbott Laboratories could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Abbott Laboratories when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Abbott Laboratories - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Abbott Laboratories to buy it.
The correlation of Abbott Laboratories is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Abbott Laboratories moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Abbott Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Abbott Laboratories can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please continue to the analysis of Abbott Laboratories Correlation against competitors. Note that the Abbott Laboratories information on this page should be used as a complementary analysis to other Abbott Laboratories' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Complementary Tools for Abbott Stock analysis

When running Abbott Laboratories price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Is Abbott Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abbott Laboratories. If investors know Abbott will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abbott Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
0.37
Market Capitalization
186 B
Quarterly Revenue Growth YOY
0.14
Return On Assets
0.0856
Return On Equity
0.22
The market value of Abbott Laboratories is measured differently than its book value, which is the value of Abbott that is recorded on the company's balance sheet. Investors also form their own opinion of Abbott Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Abbott Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abbott Laboratories' market value can be influenced by many factors that don't directly affect Abbott Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abbott Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine Abbott Laboratories value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abbott Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.